Gonorrhea Azithromycin Resistance Rises in European Economic Area
A genomic surveillance study published in The Lancet Microbe reveals azithromycin resistance in *Neisseria gonorrhoeae* increased to 9.4% in 2020 from 8.0% in 2018 across 21 European Economic Area countries. This escalating trend underscores a significant global antimicrobial resistance crisis for gonorrhea, which the WHO identifies as a high-priority organism due to its rapid resistance acquisition.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai